Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19

Zeming Liu,Jinpeng Li,Danyang Chen,Rongfen Gao,Wen Zeng,Sichao Chen,Yihui Huang,Jianglong Huang,Wei Long,Man Li,Liang Guo,Xinghuan Wang,Xiaohui Wu
DOI: https://doi.org/10.3389/fphar.2020.01093
IF: 5.6
2020-07-17
Frontiers in Pharmacology
Abstract:<span><strong>Background:</strong> Interleukin-6 (IL-6), a proinflammatory cytokine, has been reported to be associated with disease severity and mortality in patients with coronavirus disease 2019 (COVID-19). Yet, dynamic changes in IL-6 levels and their prognostic value as an indicator of lung injury in COVID-19 patients have not been fully elucidated.<strong>Objective:</strong> To validate whether IL-6 levels are associated with disease severity and mortality and to investigate whether dynamic changes in IL-6 levels might be a predictive factor for lung injury in COVID-19 patients.<strong>Methods:</strong> This retrospective, single-center study included 728 adult COVID-19 patients and used data extracted from electronic medical records for analyses.<strong>Results:</strong> The mortality rate was higher in the elevated IL-6 group than in the normal IL-6 group (0.16 <i>vs</i> 5%). Cox proportional hazards and logistic regression analyses for survival (adjusted hazard ratio, 10.39; 95% confidence interval [CI], 1.09–99.23; <i>p</i> = 0.042) and disease severity (adjusted odds ratio, 3.56; 95% CI, 2.06–6.19; <i>p</i> &lt; 0.001) revealed similar trends. Curve-fitting analyses indicated that patient computed tomography (CT) scores peaked on days 22 and 24. An initial decline in IL-6 levels on day 16 was followed by resurgence to a peak, nearly in tandem with the CT scores.<strong>Conclusion:</strong> Increased IL-6 level may be an independent risk factor for disease severity and in-hospital mortality and dynamic IL-6 changes may serve as a potential predictor for lung injury in Chinese COVID-19 patients. These findings may guide future treatment of COVID-19 patients.</span>
pharmacology & pharmacy
What problem does this paper attempt to address?